COMPARING THE COMPREHENSION OF PARENTAL INFORMED CONSENT AND THE CORRESPONDING MINOR ASSENT DOCUMENT
Links to Files
Permanent Link
Author/Creator
Author/Creator ORCID
Date
Type of Work
Department
Hood College Biology
Program
Biomedical and Environmental Science
Citation of Original Publication
Rights
Subjects
Abstract
The informed consent process has had a long history which led to the
development of explicit requirements regarding the information disclosed to adult
subjects in clinical trials. There are very few similar requirements for the information
that is disclosed to a minor who participates in the same research. This study aims to
examine the difference in the understanding of an adult consent document as compared to
its respective child assent document from the same trial.
Two document pairs were selected based upon the presence of the 14 required and
additional elements of informed consent as described in 21 CFR 50.25. In the first pair
("consistent"), there was very little difference in the number of these elements presented;
the second pair ("inconsistent") had a far greater difference. A total of 131 volunteers
each read one of the documents and answered a series of written questions designed to
analyze their understanding of the trial and their feelings about participation.
Results were tabulated, and the difference in understanding between each consent
and its respective assent was calculated. Then, the differences in understanding between
the two pairs were compared. Analysis showed an approximate 20% difference in
understanding between the pairs. Data was also analyzed to determine how the lack of
elements in the assent documents would affect the volunteer s willingness to participate.
Close to 40% of the individuals in both assent groups who declined to participate in the
described trial attributed this decision to the lack of at least one element. This diminished
understanding and difference in participation suggest that a reevaluation of the assent
process may be useful in order to respect the autonomy of the minor clinical trial
participant.
